Mendus deltar i flera konferenser i juni 2023
Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier som tar sig an tumöråterfall, tillkännager idag sitt deltagande i följande kommande investerar- och industrikonferenser:
Redeye Growth Day
Online, 1 juni 2023
Mendus VD Erik Manting kommer att delta i en frågestund den 1 juni. Ytterligare information inklusive nedladdningsbar företagspresentation finns tillgänglig via:
https://www.redeye.se/events/871323/redeye-growth-day
BIO International Convention
Boston, USA, 5-8 juni 2023
Erik Manting. VD på Mendus, kommer att medverka pa konferensen.
https://www.bio.org/events/bio-international-convention
EHA2023 Hybrid Congress
Frankfurt, Tyskland och online, 8-11 juni, 2023
Mendus kommer att presentera uppdateringar avseende immunmonitoreringssdata från
ADVANCE II-studien och framsteg avseende företagets program for NK-cellterapi.
https://ehaweb.org/congress/eha2023-hybrid-congress/eha2023/
FÖR MER INFORMATION VÄNLIGEN KONTAKTA:
Erik Manting
VD
E-post: ir@mendus.com
INVESTOR RELATIONS
Corey Davis
LifeSci Advisors, LLC
Telefon: + 1 212-915-2577
E-post: cdavis@lifesciadvisors.com
MEDIAKONTAKTER
Mario Brkulj
Valency Communications
Telefon: +49 160 9352 9951
E-post: mbrkulj@valencycomms.eu
OM MENDUS AB (PUBL)
Mendus förändrar behandlingen av cancer genom att ta itu med tumöråterfall och förbättra överlevnadsresultaten för cancerpatienter, samtidigt som livskvaliteten bevaras. Vi utnyttjar vår oöverträffade expertis inom allogen dendritcellsbiologi för att utveckla en avancerad klinisk pipeline av nya, lagringsbara, cellbaserade immunterapier som kombinerar klinisk effekt med en godartad säkerhetsprofil. Mendus är baserat i Sverige och Nederländerna och handlas på Nasdaq Stockholm under tickern IMMU.ST. http://www.mendus.com/
Bilaga
För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.
Om
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Följ GlobeNewswire by notified
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från GlobeNewswire by notified
Atlantica Reports First Quarter 2024 Financial Results8.5.2024 13:23:11 CEST | Press release
Revenue for the first quarter of 2024 remained stable at $242.9 million, compared with $242.5 million in the first quarter of 2023.Adjusted EBITDA was $164.2 million, a 0.9%1 year-over-year decrease on a comparable basis.Net loss for the first quarter of 2024 attributable to the Company was $5.4 million, compared with a net loss of $11.0 million in the first quarter of 2023.Operating Cash Flow increase of 57.3% year-over-year up to $65.6 million. Signed a 15-year PPA for a 100 MW solar + storage project in California.Closed the acquisition of two wind assets in operation in the UK at 6.6x EV2 / EBITDA3 multiple.Quarterly dividend of $0.445 per share approved by the Board of Directors.Strategic Review ongoing. May 8, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”) today reported its financial results for the first quarter of 2024. Revenue for the first quarter of 2024 was $242.9 million, a 0.2% increase compared with the first quarter of 2023.
Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions8.5.2024 13:08:18 CEST | Press release
PRESS RELEASE Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions Shareholders approve a total dividend of €2.08 per ordinary share Alphen aan den Rijn – May 8, 2024 – Wolters Kluwer (Euronext: WKL), a global leader of professional information, software solutions, and services, announces that all resolutions were adopted as proposed at today’s Annual General Meeting of Shareholders (AGM). Composition Supervisory Board David Sides has been appointed as a member of the Supervisory Board of Wolters Kluwer for a term of four years. Mr. Sides is President and CEO of NextGen Healthcare, a leading provider of innovative technology solutions focused on ambulatory care. Sophie Vandebroek has been reappointed as a member of the Supervisory Board for a second term of four years, and Jack de Kreij has been reappointed for a two-year term. Jeanette Horan, whose second four-year term expired after the AGM, regretfully has informed Wolters Kluwer that she is not availabl
Brookfield Asset Management Announces Strong First Quarter Results8.5.2024 12:45:00 CEST | Press release
Insurance Flows and Castlelake Add $75 Billion of AUM Since Quarter End $106 Billion of Dry Powder Available to Invest BROOKFIELD, NEWS, May 08, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) today announced financial results for the quarter ended March 31, 2024. Connor Teskey, President of Brookfield Asset Management stated, “We are off to a strong start in 2024 and are seeing accelerating momentum across our business as transaction activity picks up. We raised $20 billion of capital during the first quarter ($10 billion since our last earnings release), and with more than $100 billion of dry powder to invest, both the diversity of our business mix and our global footprint mean that we remain very well-positioned to capture investment opportunities.” He continued, “We recently completed a $50 billion asset management mandate with American Equity Investment Life (AEL) and announced our intention to acquire a majority stake in Castlelake, a leader in ass
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights8.5.2024 12:45:00 CEST | Press release
COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, COMP006 trial top-line data expected mid-2025Compass announces positive phase 2 COMP360 data in post-traumatic stress disorder (PTSD)Michael Gold to join Compass as Head of R&DCompass enters into additional commercial collaborations, including with Reliant Medical Group, part of Optum Care Cash position of $262.9 million at March 31, 2024 Conference call May 8 at 8:00 am ET (1:00 pm UK) LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2024 and provided an update on recent business progress. Kabir Nath, Chief Executive Officer, said, “We were pleased to see the positive results from the phase 2 PTSD study, a condition with significant unmet nee
Temenos Multifonds extends partnership with Citi Securities Services to consolidate global funds services on Multifonds SaaS8.5.2024 12:36:51 CEST | Press release
Move to Multifonds SaaS enables Citi Securities Services to manage its global business efficiently on a single platform GENEVA, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Today, Temenos (SIX: TEMN) announced that Multifonds has extended its relationship with Citi Securities Services to consolidate its current regional fund accounting operation into a global operating model on Temenos Multifonds delivered as SaaS. Citi Securities Services provides end-to-end services for asset managers globally, using Multifonds as part of its existing investment accounting platform. The move to a global operating model for its global fund services business and from an on-premise system to Multifonds SaaS enables Citi Securities Services to manage its business across multiple geographies and asset classes efficiently on a single platform which includes delivering fund accounting services earlier in the day across all time zones. Citi's Global Head of Securities Services, Okan Pekin, commented: “The m